Hunink MGM, Weinstein MC, Wittenberg E, et al. Decision making in health and medicine: Integrating evidence and values. Cambridge: Cambridge University Press; 2014.
Fenwick E, Claxton K, Sculpher M, Briggs A. Improving the efficiency and relevance of health technology assessment: The role of decision analytic modelling. Centre for Health Economics Discussion Paper 179. York: Centre for Health Economics, University of York; 2000.
Djulbegovic B, Guyatt GH. Progress in evidence-based medicine: a quarter century on. Lancet. 2017;390:415–23.
Guyatt G, Jaeschke R, Wilson MC, et al. What is evidence-based medicine? In: Guyatt GRD, Meade MO, Cook DJ, editors., et al., Users’ guides to the medical literature: a manual for evidence-based clinical practice. 3rd ed. McGraw Hill; 2015.
Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2006.
Caro JJ, Briggs AH, Siebert U, Kuntz KM. Modeling good research practices overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1. Med Decis Making. 2012;32:667–77.
Roberts M, Russell LB, Paltiel AD, et al. Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2. Med Decis Making. 2012;32:678–89.
Briggs AH, Weinstein MC, Fenwick EA, et al. Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6. Med Decis Making. 2012;32:722–32.
Eddy DM, Hollingworth W, Caro JJ, et al. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–7. Med Decis Making. 2012;32:733–43.
Fenwick E, Steuten L, Knies S, et al. Value of information analysis for research decisions—an introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force. Value in Health. 2020;23:139–50.
Rothery C, Strong M, Koffijberg H, et al. Value of information analytical methods: report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force. Value in Health. 2020;23:277–86.
Article PubMed PubMed Central Google Scholar
Sculpher M, Drummond MF, Buxton MJ. The iterative use of economic evaluation as part of the process of health technology assessment. J Health Serv Res Policy. 1997;2:26–30.
Article CAS PubMed Google Scholar
Banta HD, Thacker SB. The case for reassessment of health care technology: once is not enough. JAMA. 1990;264:235–40.
Article CAS PubMed Google Scholar
Claxton K, Sculpher M, Drummond M. A rational framework for decision making by the National Institute For Clinical Excellence (NICE). Lancet. 2002;360:711–5.
Griffin SC, Claxton KP, Palmer SJ, Sculpher MJ. Dangerous omissions: The consequences of ignoring decision uncertainty. Health Econ. 2011;20:212–24.
O’Reilly D, Audas R, Campbell K, et al. Evidence-based decision making 3: health technology assessment. Methods Mol Biol. 2021;2249:429–54.
Article CAS PubMed Google Scholar
Bertram MY, Lauer JA, Stenberg K, Edejer TTT. Methods for the economic evaluation of health care interventions for priority setting in the health system: an update from WHO CHOICE. Int J Health Policy Manag. 2021;10(11):673–7.
PubMed PubMed Central Google Scholar
Mitchell PM. Wellcome trust-funded monographs and book chapters the cost-effectiveness of what in health and care? In: Schildmann J, Buch C, Zerth J, editors. Defining the value of medical interventions: normative and empirical challenges. Stuttgart: Kohlhammer Verlag. © W. Kohlhammer GmbH; 2021.
Udeh BL. Economic evaluation studies. Chest. 2020;158:S88-s96.
Catalá-López F, Caulley L, Ridao M, et al. Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis. BMJ Open. 2020;10: e034463.
Article PubMed PubMed Central Google Scholar
Walker S, Griffin S, Asaria M, et al. Striving for a societal perspective: a framework for economic evaluations when costs and effects fall on multiple sectors and decision makers. Appl Health Econ Health Policy. 2019;17:577–90.
Article PubMed PubMed Central Google Scholar
Mauskopf J. Multivariable and structural uncertainty analyses for cost-effectiveness estimates: back to the future. Value Health. 2019;22:570–4.
Alarid-Escudero F, Krijkamp EM, Pechlivanoglou P, et al. A Need for Change! A coding framework for improving transparency in decision modeling. Pharmacoeconomics. 2019;37:1329–39.
Article PubMed PubMed Central Google Scholar
Sculpher M, Claxton K, Pearson SD. Developing a Value Framework: The Need to Reflect the Opportunity Costs of Funding Decisions. Value Health. 2017;20:234–9.
Squires H, Chilcott J, Akehurst R, et al. A Framework for Developing the Structure of Public Health Economic Models. Value Health. 2016;19:588–601.
Wilkinson T, Sculpher MJ, Claxton K, et al. The international decision support initiative reference case for economic evaluation: an aid to thought. Value Health. 2016;19:921–8.
Rautenberg T, Hulme C, Edlin R. Methods to construct a step-by-step beginner’s guide to decision analytic cost-effectiveness modeling. Clinicoecon Outcomes Res. 2016;8:573–81.
Article PubMed PubMed Central Google Scholar
Tsoi B, O’Reilly D, Jegathisawaran J, et al. Systematic narrative review of decision frameworks to select the appropriate modelling approaches for health economic evaluations. BMC Res Notes. 2015;8:244.
Article CAS PubMed PubMed Central Google Scholar
McLaughlin N, Ong MK, Tabbush V, et al. Contemporary health care economics: an overview. Neurosurg Focus. 2014;37:E2.
Espinoza MA, Manca A, Claxton K, Sculpher MJ. The value of heterogeneity for cost-effectiveness subgroup analysis: conceptual framework and application. Med Decis Making. 2014;34:951–64.
Article PubMed PubMed Central Google Scholar
Kaltenthaler E, Essat M, Tappenden P, Paisley S. Identification and review of cost-effectiveness model parameters: a qualitative study. Int J Technol Assess Health Care. 2014;30:333–40.
Kaltenthaler E, Tappenden P, Paisley S. Reviewing the evidence to inform the population of cost-effectiveness models within health technology assessments. Value Health. 2013;16:830–6.
Siebert U, Rochau U, Claxton K. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence. Z Evid Fortbild Qual Gesundhwes. 2013;107:575–84.
Dias S, Welton NJ, Sutton AJ, Ades AE. Evidence synthesis for decision making 1: introduction. Med Decis Making. 2013;33:597–606.
Article PubMed PubMed Central Google Scholar
Dias S, Welton NJ, Sutton AJ, Ades AE. Evidence synthesis for decision making 5: the baseline natural history model. Med Decis Making. 2013;33:657–70.
Article PubMed PubMed Central Google Scholar
Dias S, Sutton AJ, Welton NJ, Ades AE. Evidence synthesis for decision making 6: embedding evidence synthesis in probabilistic cost-effectiveness analysis. Med Decis Making. 2013;33:671–8.
Article PubMed PubMed Central Google Scholar
Ades AE, Caldwell DM, Reken S, et al. Evidence synthesis for decision making 7: a reviewer’s checklist. Med Decis Making. 2013;33:679–91.
Article CAS PubMed PubMed Central Google Scholar
Grutters JP, Sculpher M, Briggs AH, et al. Acknowledging patient heterogeneity in economic evaluation: a systematic literature review. Pharmacoeconomics. 2013;31:111–23.
Claxton K, Palmer S, Longworth L, et al. Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development. Health Technol Assess. 2012;16:1–323.
Article CAS PubMed Google Scholar
Jackson CH, Bojke L, Thompson SG, et al. A framework for addressing structural uncertainty in decision models. Med Decis Making. 2011;31:662–74.
Kopec JA, Finès P, Manuel DG, et al. Validation of population-based disease simulation models: a review of concepts and methods. BMC Public Health. 2010;10:710.
Article PubMed PubMed Central Google Scholar
Jackson CH, Sharples LD, Thompson SG. Structural and parameter uncertainty in Bayesian cost-effectiveness models. J R Stat Soc Ser C Appl Stat. 2010;59:233–53.
Comments (0)